Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to 0.1%.

  • Corcept Therapeutics' Return on Capital Employed fell 1300.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 1300.0%. This contributed to the annual value of 0.23% for FY2024, which is 200.0% up from last year.
  • As of Q3 2025, Corcept Therapeutics' Return on Capital Employed stood at 0.1%, which was down 1300.0% from 0.15% recorded in Q2 2025.
  • In the past 5 years, Corcept Therapeutics' Return on Capital Employed registered a high of 0.34% during Q1 2022, and its lowest value of 0.1% during Q3 2025.
  • Its 5-year average for Return on Capital Employed is 0.22%, with a median of 0.22% in 2024.
  • In the last 5 years, Corcept Therapeutics' Return on Capital Employed surged by 1300bps in 2022 and then plummeted by -1500bps in 2023.
  • Over the past 5 years, Corcept Therapeutics' Return on Capital Employed (Quarter) stood at 0.27% in 2021, then dropped by -15bps to 0.23% in 2022, then fell by -8bps to 0.21% in 2023, then fell by -4bps to 0.2% in 2024, then crashed by -50bps to 0.1% in 2025.
  • Its last three reported values are 0.1% in Q3 2025, 0.15% for Q2 2025, and 0.16% during Q1 2025.